Helicokit (13c-Urea)

Helicokit’s primary application is within scientific and clinical research, where 13c‑Urea serves as a probe or reference compound.

• Investigational use in metabolic and nitrogen‑balance studies.
• Potential role as a comparator in renal function research.
• Utilized as a standard in analytical chemistry for urea quantification.
• Explored for osmotic and diuretic effect investigations.
• Employed in pre‑clinical safety and toxicology assessments.

Reported adverse events for Helicokit are limited, reflecting its investigational status.

Common

• Mild nausea or stomach discomfort.
• Transient headache.
• Light dizziness.
• Temporary fatigue.
• Minor skin irritation at the site of handling.

Serious

• Allergic reaction such as rash or itching.
• Severe skin eruption (e.g., Stevens‑Johnson‑like presentation).
• Anaphylaxis or respiratory distress.
• Acute renal impairment in susceptible individuals.
• Unexplained hypotension.

Because comprehensive safety data are not available, general precautions are recommended when handling Helicokit.

• Verify pregnancy and lactation status; safety is not established.
• Assess renal function before use, especially in patients with known kidney disease.
• Monitor liver function as metabolic pathways are unclear.
• Avoid use in individuals with documented hypersensitivity to urea derivatives.
• Employ under medical or scientific supervision.
• Store in a controlled environment to prevent degradation.

Interaction data for Helicokit are sparse; however, standard cautionary principles are applied.

Avoid

• Concurrent high‑dose diuretics that may alter nitrogen balance.
• Co‑administration with other nitrogenous compounds without supervision.

Use with caution

• Medications cleared renally (e.g., aminoglycosides, certain antivirals).
• Drugs that affect electrolyte balance (e.g., ACE inhibitors, ARBs).
• Herbal supplements with known nephrotoxic potential.
• Agents that can provoke hypersensitivity reactions.